PITX1 is a reliable biomarker for predicting prognosis in patients with oral epithelial dysplasia.

MLA

Nakabayashi, Motoki, et al. “PITX1 Is a Reliable Biomarker for Predicting Prognosis in Patients with Oral Epithelial Dysplasia.” Oncology Letters, vol. 7, no. 3, Mar. 2014, pp. 750–54. EBSCOhost, https://doi.org/10.3892/ol.2013.1775.

APA

Nakabayashi, M., Osaki, M., Kodani, I., Okada, F., Ryoke, K., Oshimura, M., Ito, H., & Kugoh, H. (2014). PITX1 is a reliable biomarker for predicting prognosis in patients with oral epithelial dysplasia. Oncology Letters, 7(3), 750–754. https://doi.org/10.3892/ol.2013.1775

Chicago

Nakabayashi, Motoki, Mitsuhiko Osaki, Isamu Kodani, Futoshi Okada, Kazuo Ryoke, Mitsuo Oshimura, Hisao Ito, and Hiroyuki Kugoh. 2014. “PITX1 Is a Reliable Biomarker for Predicting Prognosis in Patients with Oral Epithelial Dysplasia.” Oncology Letters 7 (3): 750–54. doi:10.3892/ol.2013.1775.